CClinicalTrials.gg
CompletedNCT05261659Updated Mar 14, 2022

Targeted Memory Reactivation During REM Sleep in Patients With Social Anxiety Disorder

An interventional study of Exposure Therapy and Targeted memory reactivation during REM sleep and Exposure Therapy in Social Anxiety Disorder and Sleep, sponsored by University Hospital, Geneva. Completed at 1 site in Switzerland. Open to participants aged 16 Years to 40 Years. Per ClinicalTrials.gov, last updated 2022-03-14.

Sponsored by University Hospital, Geneva · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Feb 2020, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
16 Years to 40 Years
Sex
All
01

Study summary

With this study, the investigators aim to use sleep and dreaming in order to enhance exposure therapy for social anxiety disorder (SAD), by pairing the positive feedback phase of exposure (public talk) to an auditory stimulus during wake (associated sound) and subsequently applying this stimulus during sleep (targeted memory reactivation, TMR). Exposure therapy sessions will take place in a virtual reality (VR) environment, while physiological measures during the preparation phase of public talk such as heart rate variability (HRV), skin conductance response (SCR) and subjective level of anxiety (SUDS) will be used in order to assess treatment efficiency across the sessions. Patients with SAD according to DSM-5 criteria will be included.

The main hypothesis of this study is that participants who are presented with the associated sound during sleep (TMR group) will have reduced intensity of social anxiety compared to participants with no such association (control group), after both a full night's sleep with auditory stimulation during REM sleep in the laboratory, and after 1 week of stimulation during REM sleep at home. In addition, it is expected that fear-related dreams may correlate with anxiety levels during wakefulness after 1 week of stimulation at home.

02

Conditions studied

  • Social Anxiety Disorder
  • Sleep
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 51 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University Hospital, Geneva is the lead sponsor of 372 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with social anxiety disorder (according to DSM-5 criteria and Liebowitz Social Anxiety Scale > 65)
  • aged between 16 and 40 yo
  • no current treatment for SAD (cognitive-behavioral therapy, medications)

Exclusion criteria

Exclusion Criteria:

  • mood disorder, psychosis,other anxiety disorder or other mental disorders according to DSM-5 criteria
  • sleep disorder (e.g.,insomnia disorder, obstructive sleep apnea syndrome, restless legs syndrome) according to DSM-5 criteria
  • use of psychiatric medication
  • current treatment for SAD (cognitive-behavioral therapy, medications)
  • neurological disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    TMR group

    Patients will receive a sound while they receive a positive feedback for their performance of exposure therapy (ET). They will also receive the sound during REM sleep.

    Behavioral: Exposure Therapy and Targeted memory reactivation during REM sleep

  • Active comparator
    Control group

    Patients will not receive a sound while they receive a positive feedback for their performance of exposure therapy (ET). They will receive the same sound as the experimental group during REM sleep under the same conditions.

    Behavioral: Exposure Therapy

Interventions

  • BehavioralExposure Therapy and Targeted memory reactivation during REM sleep

    Emerging evidence shows that REM sleep plays a causal role in extinction learning, emotion regulation and consolidation of emotionally positive memories. By using targeted memory reactivation (TMR), a known method where a sound is associated with a waking experience (i.e., positive feedback in this study) and strengthening it during REM sleep, the investigators aim to accelerate the remission of social anxiety disorder.

  • BehavioralExposure Therapy

    These patients will receive the classic treatment of Exposure Therapy (ET) for social anxiety disorder without any association with a sound.

06

What researchers measure

Primary outcomes

  1. Root mean square of the successive [R-R intervals] differences

    The RMSSD is used to estimate the vagally mediated changes in heart rate variability.

    Time frame: 1 day

  2. Root mean square of the successive [R-R intervals] differences

    The RMSSD is used to estimate the vagally mediated changes in heart rate variability.

    Time frame: 1 week

  3. Subjective Units of Distress Scale

    Validated rating of subjective distress on a scale of 0 to 10 (higher values reflect a worse outcome)

    Time frame: 1 day

  4. Subjective Units of Distress Scale

    Validated rating of subjective distress on a scale of 0 to 10 (higher values reflect a worse outcome)

    Time frame: 1 week

Secondary outcomes

  1. Non-specific skin conductance responses

    The skin conductance response measures sympathetic nervous system activation.

    Time frame: 1 day

  2. Non-specific skin conductance responses

    The skin conductance response measures sympathetic nervous system activation.

    Time frame: 1 week

  3. Change of fear in dreams (average of fear during the second week with stimulations minus the first week without stimulations)

    Use of a dream diary where the emotion of fear is graded in a dichotomous way (presence/absence).

    Time frame: 1 week

Other outcomes

  1. Liebowitz Social Anxiety Scale

    Validated self-report measure used to assess degree of social anxiety on a scale of 0 to 144 (higher values reflect a worse outcome)

    Time frame: 3 months

07

Study locations

1 site
  • Center for Sleep Medicine, University Hospitals of Geneva
    Geneva, 1225, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05261659
Lead sponsor
University Hospital, Geneva
Responsible party
Lampros Perogamvros (Senior Clinical Fellow, University Hospital, Geneva) — Principal investigator
First posted
Mar 2, 2022
Start date
Feb 18, 2020
Primary completion
Feb 6, 2022
Completion
Feb 6, 2022
Last update
Mar 14, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion